For: | Marano G, Traversi G, Gaetani E, Pola R, Claro AE, Mazza M. Alcohol use disorder and liver injury related to the COVID-19 pandemic. World J Hepatol 2022; 14(10): 1875-1883 [PMID: 36340751 DOI: 10.4254/wjh.v14.i10.1875] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v14/i10/1875.htm |
Number | Citing Articles |
1 |
Giuseppe Marano, Marianna Mazza, Francesco Maria Lisci, Michele Ciliberto, Gianandrea Traversi, Georgios Demetrios Kotzalidis, Domenico De Berardis, Lucrezia Laterza, Gabriele Sani, Antonio Gasbarrini, Eleonora Gaetani. The Microbiota–Gut–Brain Axis: Psychoneuroimmunological Insights. Nutrients 2023; 15(6): 1496 doi: 10.3390/nu15061496
|
2 |
Richie Manikat, Aijaz Ahmed, Donghee Kim. The Impact of Alcohol Consumption and Addiction on Liver Transplantation Programs in the COVID-19 Era. Hepatic Medicine: Evidence and Research 2023; : 141 doi: 10.2147/HMER.S384070
|
3 |
Tzavellas Elias, Efthimios Vasilopoulos , Bompori Panagiota , Abraham Seri , Adorjan Kristina , al et. Alcohol and Substance Abuse in the General Population during the COVID-19 Pandemic: Results of the COMET-G International Study. Insights on the Depression and Anxiety 2024; 8(1): 010 doi: 10.29328/journal.ida.1001041
|
4 |
A. P. Gonchar, Yu. F. Shumskaya, M. G. Mnatsakanyan, I. A. Blokhin, D. K. Zakharova, R. V. Reshetnikov, V. A. Gombolevskiy, Yu. A. Vasilev. COVID-19 impact on liver attenuation by computed tomography: a retrospective cohort study. The Siberian Journal of Clinical and Experimental Medicine 2023; 38(3): 103 doi: 10.29001/2073-8552-2023-39-3-103-109
|
5 |
Linda S Park, Rachel Kornfield, Mihret Yezihalem, Andrew Quanbeck, Jessica Mellinger, Margarita German. Testing a Digital Health App for Patients With Alcohol-Associated Liver Disease: Mixed Methods Usability Study. JMIR Formative Research 2023; 7: e47404 doi: 10.2196/47404
|
6 |
Agata Michalak, Tomasz Lach, Karolina Szczygieł, Halina Cichoż-Lach. COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?. International Journal of Molecular Sciences 2024; 25(4): 2212 doi: 10.3390/ijms25042212
|
7 |
Jakub Grabowski, Tomasz Michalski, Maciej Brosz, Aleksandra Brzozowska, Gursimran Gaba. Perceived stress and pandemic-associated risk factors in high-risk alcohol consumers during the third wave of the COVID-19 pandemic. Health Psychology Report 2024; doi: 10.5114/hpr/191490
|
8 |
Marion M. Friske, Rainer Spanagel. Chronic alcohol consumption and COVID‐19 infection risk: A narrative review. Alcohol: Clinical and Experimental Research 2023; 47(4): 629 doi: 10.1111/acer.15041
|
9 |
Sonja Banga, Alena Khromava, Laurence Serradell, Anne-Laure Chabanon, Chunshen Pan, Irisdaly Estevez, Samantha Schilsky, Hannah Kreisberg. Background incidence rates of health outcomes of interest for COVID-19 vaccine safety monitoring in a US population: a claims database analysis. BMJ Open 2024; 14(7): e083947 doi: 10.1136/bmjopen-2024-083947
|
10 |
James M. Paik, Dipam Shah, Katherine Eberly, Pegah Golabi, Linda Henry, Zobair M. Younossi, Dong Hyun Sinn. Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States’ National Vital Statistics System. PLOS ONE 2024; 19(9): e0289202 doi: 10.1371/journal.pone.0289202
|
11 |
Ellen W. Green, Isabelle S. Byers, Sasha Deutsch-Link. Closing the Care Gap: Management of Alcohol Use Disorder in Patients with Alcohol-associated Liver Disease. Clinical Therapeutics 2023; 45(12): 1189 doi: 10.1016/j.clinthera.2023.09.017
|
12 |
Madeline Pearson, Jennifer Nobes, Iain Macpherson, Lucy Gold, Michael Miller, Ellie Dow, John F. Dillon. Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality. JHEP Reports 2024; 6(6): 101062 doi: 10.1016/j.jhepr.2024.101062
|